Medtronic Granted Reprieve On CoreValve Injunction, At Least For Now
This article was originally published in The Gray Sheet
Executive Summary
The Federal Circuit Court of Appeals granted Medtronic’s request to postpone the implementation of an injunction that would have severely restricted sales of its CoreValve transcatheter aortic valve in the U.S. This means the injunction will only take effect if the appellate court rules that the injunction is proper.